Applied Genetic Technologies Corporation , a clinical stage biotechnology company developing adeno-associated virus -based gene therapies for the treatment of rare eye diseases, today announced that company management will present at two upcoming conferences. Targeting Ocular Disorders on Tuesday, October 7, 2014 at 1:55pm ET in Boston.
http://ift.tt/10f2nUe
http://ift.tt/10f2nUe
No comments:
Post a Comment